Longitudinal NT-proBNP Target Attainment and Clinical Outcomes in Heart Failure With Reduced Ejection Fraction: A Landmark Analysis of the GUIDE-IT Trial.
Listen to this summary
This secondary landmark analysis of the GUIDE-IT trial asked whether achieving longer-term NT-proBNP target attainment (≤1000 pg/mL across pre-landmark visits) predicts lower risk of all-cause hospitalization or death in HFrEF patients who were event-free at 180 days. Among 324 participants, greater attainment was associated with lower risk (each 10% increase HR 0.89; ≥50% vs <50% attainment HR 0.44), but this prognostic benefit was no longer significant after adjusting for the most recent NT-proBNP value (HR 0.97, P=0.51). The authors conclude that longitudinal target attainment carries prognostic information that largely overlaps with the single most recent NT-proBNP measurement, rather than adding independent value.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from The American journal of cardiology
View all →Nov 19, 2026 · The American journal of cardiology
Eximer Laser Coronary Atherectomy in the Current era of Complex Percutenoues Coronary Intervention: New Insights from the ACCELERATE (eAst siCily exCimEr LasER ATherEctomy) Registry.
Nov 19, 2026 · The American journal of cardiology
Cardiovascular Outcomes of Semaglutide in Adults With Congenital Heart Disease.
Nov 19, 2026 · The American journal of cardiology
Timing of Coronary Angiography After Successful Fibrinolysis and Clinical Outcomes in ST-Segment Elevation Myocardial Infarction Patients.
Nov 18, 2026 · The American journal of cardiology
Effect of High-Intensity Statin Therapy on Coronary Plaque Composition Assessed by Machine Learning-Based Optical Coherence Tomography Analysis.
Nov 18, 2026 · The American journal of cardiology
Differential Reverse Remodeling but Preserved Clinical Benefit of Sacubitril/Valsartan in Ischemic vs Non‑Ischemic HFrEF.
Nov 18, 2026 · The American journal of cardiology
Artificial Intelligence and Cardiovascular Disease Prevention: Newton's Second Law Readdressed with a Cautionary Note.
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


